出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年5月
バイオバンキング市場 : 製品とサービス (機器、消耗品、サービス、ソフトウェア)、サンプルの種類 (血液、組織、核酸、細胞株)、所有権、用途 (再生医療、ライフサイエンス、臨床研究)、エンドユーザー – 2028年までの世界予測
Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User – Global Forecast to 2028
| ページ数 | 324 |
| 図表数 | 426 |
| 種別 | 英文調査報告書 |
| 価格 |
The global biobanking market is projected to reach USD 5.0 billion by 2028 from USD 2.9 billion in 2023, at a CAGR of 11.4% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by the demand for cord blood stem cell preservation.
The increasing trend of preserving cord blood stem cells from newborns has led to a significant increase in the number of cord blood banks and biobanks that specialize in the preservation of cord blood stem cells. These biobanks store cord blood samples for long-term use and provide services, and are a valuable resource for researchers and clinicians studying regenerative medicine.
“The consumables segment accounted for the second-largest share by product during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product in the global biobanking market. Biobanking consumables primarily include reagents and media, nucleic acid extraction kits, surface disinfectants, collection kits, swabs, containers, and syringes. Consumables are indispensable and integral components of biobanking. With the rising demand for the biobanking of cells, tissues, and organs, the requirement for biobanking equipment and consumables has increased significantly. Furthermore, there is a growing demand for storage equipment in the biobanking industry, with an increasing number of samples being stored for research and clinical applications. These trends underscore the importance of reliable and effective storage consumables in maintaining the integrity and accessibility of valuable biological specimens
“Europe: The second largest region in the biobanking market”
Europe is the second-largest market for biobanking after North America. The European biobanking market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. One notable factor is the increasing focus on personalized medicine and precision healthcare, which has created a burgeoning demand for high-quality biological samples and associated data. Furthermore, the advancements in genomic research and the advent of next-generation sequencing technologies have stimulated the need for vast repositories of biological materials, fueling the growth of biobanking activities across Europe. This upward trajectory in the European biobanking market exemplifies its vital role in facilitating biomedical research, enabling the development of innovative diagnostics, therapies, and treatments for improved patient outcomes
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level – 45%, D-level – 30%, and Others – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• PHC Holdings Corporation (Japan)
• Becton, Dickinson and Company (US)
• QIAGEN N.V. (Germany)
• Merck KGaA (Germany)
• Avantor, Inc. (US)
• Cryoport, Inc. (US)
• Tecan Trading AG (Switzerland)
• Azenta, Inc. (US)
• Greiner Holding AG (Austria)
• Hamilton Company (US)
• Micronic (Netherlands)
• AMSBIO (UK)
• Bay Biosciences LLC (US)
• BioKryo (Germany)
• SPT Labtech (UK)
• ASKION GmbH (Germany)
• Cell&Co BioServices (France)
• Ziath Ltd. (UK)
• CTIBiotech (France)
• Cureline (US)
• Firalis Group (France)
• Sopachem (Netherlands)
• ProteoGenex (US)
• US Biolab Corporation, Inc. (US)
Research Coverage:
This report provides a detailed picture of the biobanking market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, sample type, storage type, ownership, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
• Analysis of key drivers (growing investments and funding for biobanks, focus on genetic testing and precision medicine, increasing trend in preservation of cord blood stem cells from newborns, favorable funding scenario for research related to regenerative medicine), restraints (High cost of automated equipment, issues related to biospecimen sample management), opportunities (emerging countries to provide lucrative opportunities), and challenges (high operational cost of biobanks, storage of samples) influencing the growth of the market.
• Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the biobanking market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biobanking market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US) and among others in the market.
目次
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 32
1.5 RESEARCH LIMITATIONS 32
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 33
1.7.1 IMPACT OF ECONOMIC RECESSION 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Breakdown of primaries 37
2.2 MARKET ESTIMATION METHODOLOGY 38
FIGURE 2 BIOBANKING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 38
FIGURE 3 MARKET SIZE ESTIMATION – COMPANY REVENUE ANALYSIS (2022) 38
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 39
FIGURE 4 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 39
2.3 MARKET GROWTH RATE PROJECTIONS 41
FIGURE 5 BIOBANKING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41
FIGURE 6 BIOBANKING MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
2.5 STUDY ASSUMPTIONS 44
2.6 IMPACT OF RECESSION ON BIOBANKING MARKET 44
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027 44
2.7 RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
FIGURE 8 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 9 BIOBANKING MARKET, BY STORAGE TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 10 BIOBANKING MARKET, BY SAMPLE TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 11 BIOBANKING MARKET, BY OWNERSHIP, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 BIOBANKING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 13 BIOBANKING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BIOBANKING MARKET 50
4 PREMIUM INSIGHTS 51
4.1 BIOBANKING MARKET OVERVIEW 51
FIGURE 15 GROWING INVESTMENTS AND FUNDING FOR BIOBANKS TO DRIVE MARKET 51
4.2 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE AND COUNTRY (2022) 52
FIGURE 16 MANUAL STORAGE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN BIOBANKING MARKET IN 2022 52
4.3 BIOBANKING MARKET SHARE, BY APPLICATION, 2023 VS. 2028 52
FIGURE 17 REGENERATIVE MEDICINE SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028 52
4.4 BIOBANKING MARKET SHARE, BY END USER (2023) 53
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53
4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 20 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
TABLE 2 BIOBANKING MARKET: IMPACT ANALYSIS 55
5.2.1 DRIVERS 55
5.2.1.1 Growing investments and funding for biobanks 55
5.2.1.2 Focus on genetic testing and precision medicine 56
5.2.1.3 Increasing trend in preservation of cord blood stem cells from newborns 56
5.2.1.4 Favorable funding scenario for research related to regenerative medicine 57
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of automated equipment 58
5.2.2.2 Issues related to biospecimen sample management 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging economies to provide lucrative opportunities 59
5.2.4 CHALLENGES 59
5.2.4.1 High operational cost of biobanks 59
5.2.4.2 Storage of samples 59
5.3 RANGES/SCENARIOS 60
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61
FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOBANKING PRODUCT PROVIDERS 61
5.5 PRICING ANALYSIS 61
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 61
TABLE 3 PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER 61
5.5.2 AVERAGE SELLING PRICE TREND 61
5.6 VALUE CHAIN ANALYSIS 62
FIGURE 23 VALUE CHAIN ANALYSIS OF BIOBANKING MARKET 62
5.7 SUPPLY CHAIN ANALYSIS 63
FIGURE 24 BIOBANKING MARKET: SUPPLY CHAIN ANALYSIS 64
5.8 ECOSYSTEM ANALYSIS 64
FIGURE 25 ECOSYSTEM ANALYSIS: BIOBANKING MARKET 64
TABLE 4 SUPPLY CHAIN ECOSYSTEM 65
5.9 PATENT ANALYSIS 66
FIGURE 26 PATENT APPLICATIONS FOR BIOBANKING MARKET, JANUARY 2013–APRIL 2023 66
5.10 KEY CONFERENCES AND EVENTS IN 2023 67
TABLE 5 BIOBANKING MARKET: LIST OF CONFERENCES AND EVENTS 67
5.11 REGULATORY ANALYSIS 68
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 68
5.12 PORTER’S FIVE FORCES ANALYSIS 69
TABLE 6 BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS 69
5.12.1 THREAT OF NEW ENTRANTS 69
5.12.2 THREAT OF SUBSTITUTES 69
5.12.3 BARGAINING POWER OF BUYERS 69
5.12.4 BARGAINING POWER OF SUPPLIERS 70
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 70
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 70
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOBANKING PRODUCTS 70
5.13.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS AMONG END USERS 71
FIGURE 28 KEY BUYING CRITERIA FOR END USERS 71
6 BIOBANKING MARKET, BY PRODUCT & SERVICE 72
6.1 INTRODUCTION 73
TABLE 7 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 73
6.2 EQUIPMENT 73
TABLE 8 BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 74
TABLE 9 BIOBANKING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 10 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 11 EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 12 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 13 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
6.2.1 STORAGE EQUIPMENT 76
6.2.1.1 Storage solutions for biobanking to ensure integrity and longevity of biological samples 76
TABLE 14 STORAGE EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 15 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 16 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 17 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 18 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
6.2.2 SAMPLE ANALYSIS EQUIPMENT 78
6.2.2.1 Ensures sample integrity, traceability, and preservation 78
TABLE 19 SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 20 NORTH AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 21 EUROPE: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 22 ASIA PACIFIC: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 23 LATIN AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
6.2.3 SAMPLE PROCESSING EQUIPMENT 80
6.2.3.1 Demand for reliable biobanking equipment to propel adoption 80
TABLE 24 SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 25 NORTH AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 26 EUROPE: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 27 ASIA PACIFIC: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 28 LATIN AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.2.4 SAMPLE TRANSPORT EQUIPMENT 83
6.2.4.1 Need for reliable transport equipment to maintain sample integrity and quality to drive market 83
TABLE 29 SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 30 NORTH AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 31 EUROPE: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 32 ASIA PACIFIC: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 33 LATIN AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.3 CONSUMABLES 85
TABLE 34 BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
TABLE 35 BIOBANKING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 36 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 37 EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 38 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 39 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3.1 STORAGE CONSUMABLES 87
6.3.1.1 Play crucial role in preserving integrity and viability of samples 87
TABLE 40 STORAGE CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 41 NORTH AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 42 EUROPE: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 43 ASIA PACIFIC: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 44 LATIN AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.3.2 ANALYSIS CONSUMABLES 90
6.3.2.1 Increasing demand for sample analysis to fuel adoption 90
TABLE 45 ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 46 NORTH AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 47 EUROPE: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 48 ASIA PACIFIC: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 49 LATIN AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.3.3 PROCESSING CONSUMABLES 92
6.3.3.1 Use of sample processing consumables for efficient biobanking to drive growth 92
TABLE 50 PROCESSING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 51 NORTH AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 52 EUROPE: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 53 ASIA PACIFIC: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 54 LATIN AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.3.4 COLLECTION CONSUMABLES 94
6.3.4.1 Demand for efficient sample handling to drive adoption 94
TABLE 55 COLLECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 56 NORTH AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 57 EUROPE: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 58 ASIA PACIFIC: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 59 LATIN AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.4 SERVICES 96
TABLE 60 BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 61 BIOBANKING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 62 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 63 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 64 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 65 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.4.1 STORAGE SERVICES 99
6.4.1.1 Increasing number of biological samples to fuel demand for storage services 99
TABLE 66 STORAGE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 67 NORTH AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 68 EUROPE: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 69 ASIA PACIFIC: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 70 LATIN AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.4.2 PROCESSING SERVICES 101
6.4.2.1 Critical for preparation of samples for storage and analysis 101
TABLE 71 PROCESSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 72 NORTH AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 73 EUROPE: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 74 ASIA PACIFIC: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 75 LATIN AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.4.3 TRANSPORT SERVICES 103
6.4.3.1 Help in facilitating biobanking operations 103
TABLE 76 TRANSPORT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 77 NORTH AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 78 EUROPE: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 79 ASIA PACIFIC: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 80 LATIN AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
6.4.4 SUPPLY SERVICES 106
6.4.4.1 Supply services for biobanking to enable research and discovery 106
TABLE 81 SUPPLY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 82 NORTH AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 83 EUROPE: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 84 ASIA PACIFIC: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 85 LATIN AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
6.5 SOFTWARE 108
6.5.1 RISING ADOPTION OF BIOBANKING SOFTWARE TO MANAGE BIOLOGICAL SAMPLES TO DRIVE GROWTH 108
TABLE 86 BIOBANKING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 87 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 88 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 89 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 90 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
7 BIOBANKING MARKET, BY STORAGE TYPE 111
7.1 INTRODUCTION 112
TABLE 91 BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 112
7.2 MANUAL STORAGE 112
7.2.1 POPULARITY OF MANUAL STORAGE OVER AUTOMATED STORAGE TO SUPPORT MARKET GROWTH 112
TABLE 92 BIOBANKING MARKET FOR MANUAL STORAGE, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 93 NORTH AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 94 EUROPE: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 95 ASIA PACIFIC: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 96 LATIN AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.3 AUTOMATED STORAGE 115
7.3.1 EFFICIENT TRACKING OF SAMPLES AND REDUCTION OF MANUAL ERRORS TO DRIVE MARKET 115
TABLE 97 BIOBANKING MARKET FOR AUTOMATED STORAGE, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 98 NORTH AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 99 EUROPE: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 100 ASIA PACIFIC: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 101 LATIN AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 117
8 BIOBANKING MARKET, BY SAMPLE TYPE 118
8.1 INTRODUCTION 119
TABLE 102 BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 119
8.2 BLOOD PRODUCTS 119
8.2.1 USE IN WIDE RANGE OF APPLICATIONS TO PROPEL MARKET 119
TABLE 103 BIOBANKING MARKET FOR BLOOD PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 104 NORTH AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 105 EUROPE: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 106 ASIA PACIFIC: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 107 LATIN AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 122
8.3 HUMAN TISSUES 122
8.3.1 PIVOTAL ROLE IN FACILITATING SCIENTIFIC DISCOVERIES AND IMPROVING PATIENT CARE TO DRIVE MARKET 122
TABLE 108 BIOBANKING MARKET FOR HUMAN TISSUES, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 109 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 110 EUROPE: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 111 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 112 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
8.4 CELL LINES 125
8.4.1 SERVE AS VALUABLE RESOURCES IN BIOBANKING 125
TABLE 113 BIOBANKING MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 114 NORTH AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 115 EUROPE: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 116 ASIA PACIFIC: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 117 LATIN AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 127
8.5 NUCLEIC ACIDS 127
8.5.1 GROWING DEMAND FOR STORAGE AND ANALYSIS OF NUCLEIC ACIDS TO DRIVE MARKET 127
TABLE 118 BIOBANKING MARKET FOR NUCLEIC ACIDS, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 119 NORTH AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 120 EUROPE: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 121 ASIA PACIFIC: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 122 LATIN AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 130
8.6 BIOLOGICAL FLUIDS 130
8.6.1 SERVE AS VALUABLE RESOURCES FOR RESEARCHERS AND CLINICIANS IN STUDYING DISEASES 130
TABLE 123 BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 124 NORTH AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 125 EUROPE: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 126 ASIA PACIFIC: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 127 LATIN AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 133
8.7 HUMAN WASTE PRODUCTS 133
8.7.1 USE OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET 133
TABLE 128 BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 129 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 130 EUROPE: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 131 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 132 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
9 BIOBANKING MARKET, BY OWNERSHIP 136
9.1 INTRODUCTION 137
TABLE 133 BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 137
9.2 UNIVERSITIES 137
9.2.1 IMPORTANCE OF BIOBANKING IN ADVANCING RESEARCH TO DRIVE MARKET 137
TABLE 134 UNIVERSITY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 135 NORTH AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 136 EUROPE: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 137 ASIA PACIFIC: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 138 LATIN AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
9.3 NATIONAL/REGIONAL AGENCIES 140
9.3.1 SUSTAINED FUNDING AND STANDARDIZED PRACTICES TO SUPPORT MARKET GROWTH 140
TABLE 139 NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 140 NORTH AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 141 EUROPE: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 142 ASIA PACIFIC: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 143 LATIN AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
9.4 NON-PROFIT ORGANIZATIONS 142
9.4.1 FOCUS OF NON-PROFIT ORGANIZATIONS ON ADVANCING RESEARCH TO DRIVE MARKET 142
TABLE 144 NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 145 NORTH AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 146 EUROPE: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 147 ASIA PACIFIC: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 148 LATIN AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
9.5 PRIVATE ORGANIZATIONS 145
9.5.1 INCREASING OWNERSHIP OF BIOBANKS BY PRIVATE ORGANIZATIONS TO DRIVE MARKET 145
TABLE 149 PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 150 NORTH AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 151 EUROPE: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 152 ASIA PACIFIC: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 153 LATIN AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
10 BIOBANKING MARKET, BY APPLICATION 148
10.1 INTRODUCTION 149
TABLE 154 BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
10.2 REGENERATIVE MEDICINE 149
10.2.1 INCREASING RESEARCH AND RISING GOVERNMENT FUNDING TO DRIVE MARKET 149
TABLE 155 BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 156 NORTH AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 157 EUROPE: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 158 ASIA PACIFIC: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 159 LATIN AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
10.3 LIFE SCIENCE RESEARCH 152
10.3.1 INCREASING DEMAND AND UTILIZATION OF BIOBANKS IN LIFE SCIENCE RESEARCH APPLICATIONS TO SUPPORT MARKET GROWTH 152
FIGURE 29 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 152
TABLE 160 BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 161 NORTH AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 162 EUROPE: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 163 ASIA PACIFIC: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 164 LATIN AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
10.4 CLINICAL RESEARCH 155
10.4.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND ACCELERATED DRUG DEVELOPMENT TO PROPEL MARKET 155
TABLE 165 BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 166 NORTH AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 167 EUROPE: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 168 ASIA PACIFIC: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 169 LATIN AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 157
11 BIOBANKING MARKET, BY END USER 158
11.1 INTRODUCTION 159
TABLE 170 BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 159
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS 159
11.2.1 LARGEST END USER SEGMENT DUE TO GROWING NUMBER OF CLINICAL TRIALS AND RESEARCH STUDIES 159
TABLE 171 BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 172 NORTH AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 173 EUROPE: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 174 ASIA PACIFIC: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 175 LATIN AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 162
11.3 ACADEMIC AND RESEARCH INSTITUTES 162
11.3.1 ADVANCEMENTS IN SCIENTIFIC RESEARCH AND INNOVATION TO DRIVE MARKET 162
TABLE 176 BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 177 NORTH AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 178 EUROPE: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 179 ASIA PACIFIC: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 180 LATIN AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
11.4 HOSPITALS 165
11.4.1 USE BIOBANKING TO COLLECT, STORE, AND MANAGE PATIENT SAMPLES FOR DIAGNOSTIC PURPOSES 165
TABLE 181 BIOBANKING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 182 NORTH AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 183 EUROPE: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 184 ASIA PACIFIC: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 185 LATIN AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 167
12 BIOBANKING MARKET, BY REGION 168
12.1 INTRODUCTION 169
TABLE 186 BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 169
12.2 NORTH AMERICA 169
12.2.1 RECESSION IMPACT 170
FIGURE 30 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT 170
TABLE 187 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 188 NORTH AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 171
TABLE 189 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 190 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 191 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 192 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 172
TABLE 193 NORTH AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 173
TABLE 194 NORTH AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 173
TABLE 195 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 196 NORTH AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.2.2 US 174
12.2.2.1 Largest market in North America due to surge in genomic research 174
TABLE 197 US: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 198 US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 199 US: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 200 US: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 201 US: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 177
TABLE 202 US: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 177
TABLE 203 US: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 177
TABLE 204 US: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 205 US: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 178
12.2.3 CANADA 178
12.2.3.1 Increasing number of biobanks to support market 178
TABLE 206 CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 207 CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 208 CANADA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 209 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 210 CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 180
TABLE 211 CANADA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 181
TABLE 212 CANADA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 181
TABLE 213 CANADA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 214 CANADA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 182
12.3 EUROPE 182
12.3.1 RECESSION IMPACT 182
TABLE 215 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 216 EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 183
TABLE 217 EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 218 EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 219 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 220 EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 185
TABLE 221 EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 185
TABLE 222 EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 185
TABLE 223 EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 186
TABLE 224 EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 186
12.3.2 GERMANY 186
12.3.2.1 Largest market for biobanking in Europe 186
TABLE 225 GERMANY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 187
TABLE 226 GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 227 GERMANY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 228 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 229 GERMANY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 188
TABLE 230 GERMANY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 189
TABLE 231 GERMANY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 189
TABLE 232 GERMANY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 233 GERMANY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 190
12.3.3 UK 190
12.3.3.1 Increasing number of biobanks to support market growth 190
TABLE 234 UK: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 191
TABLE 235 UK: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 236 UK: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 237 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 238 UK: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 192
TABLE 239 UK: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 192
TABLE 240 UK: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 193
TABLE 241 UK: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 193
TABLE 242 UK: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 193
12.3.4 FRANCE 194
12.3.4.1 Robust healthcare infrastructure and advanced research capabilities to propel market 194
TABLE 243 FRANCE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 194
TABLE 244 FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 245 FRANCE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 246 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 247 FRANCE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 196
TABLE 248 FRANCE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 196
TABLE 249 FRANCE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 196
TABLE 250 FRANCE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 251 FRANCE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 197
12.3.5 ITALY 197
12.3.5.1 Emergence of private sector players to support market growth 197
TABLE 252 ITALY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 198
TABLE 253 ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 254 ITALY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 255 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 256 ITALY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 199
TABLE 257 ITALY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 200
TABLE 258 ITALY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 200
TABLE 259 ITALY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200
TABLE 260 ITALY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 201
12.3.6 SPAIN 201
12.3.6.1 Favorable government initiatives to propel market 201
TABLE 261 SPAIN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 202
TABLE 262 SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 263 SPAIN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 264 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 265 SPAIN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 203
TABLE 266 SPAIN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 203
TABLE 267 SPAIN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 204
TABLE 268 SPAIN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 269 SPAIN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 204
12.3.7 REST OF EUROPE 205
TABLE 270 REST OF EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 205
TABLE 271 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 272 REST OF EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 273 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 274 REST OF EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 207
TABLE 275 REST OF EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 207
TABLE 276 REST OF EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 207
TABLE 277 REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 278 REST OF EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 208
12.4 ASIA PACIFIC 209
12.4.1 RECESSION IMPACT 209
FIGURE 31 ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT 210
TABLE 279 ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 210
TABLE 280 ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 211
TABLE 281 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 282 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 283 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 284 ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 212
TABLE 285 ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 212
TABLE 286 ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 213
TABLE 287 ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 213
TABLE 288 ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 213
12.4.2 CHINA 214
12.4.2.1 Advanced healthcare infrastructure and increasing investments in medical research to propel market 214
TABLE 289 CHINA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 214
TABLE 290 CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 291 CHINA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 292 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 293 CHINA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 216
TABLE 294 CHINA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 216
TABLE 295 CHINA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 216
TABLE 296 CHINA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 217
TABLE 297 CHINA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 217
12.4.3 JAPAN 217
12.4.3.1 Advancements in medical research and increasing need for personalized medicine to drive market 217
TABLE 298 JAPAN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 218
TABLE 299 JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 300 JAPAN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 301 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 302 JAPAN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 219
TABLE 303 JAPAN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 220
TABLE 304 JAPAN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 220
TABLE 305 JAPAN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 220
TABLE 306 JAPAN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 221
12.4.4 INDIA 221
12.4.4.1 Demand for high-quality biological samples for medical research and development to drive market 221
TABLE 307 INDIA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 222
TABLE 308 INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 309 INDIA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 310 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 311 INDIA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 223
TABLE 312 INDIA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 223
TABLE 313 INDIA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 224
TABLE 314 INDIA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 315 INDIA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 224
12.4.5 REST OF ASIA PACIFIC 225
TABLE 316 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 225
TABLE 317 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 318 REST OF ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 319 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 320 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 227
TABLE 321 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 227
TABLE 322 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 227
TABLE 323 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 324 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 228
12.5 LATIN AMERICA 228
12.5.1 RECESSION IMPACT 229
TABLE 325 LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 229
TABLE 326 LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 230
TABLE 327 LATIN AMERICA BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 328 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 329 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 330 LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 231
TABLE 331 LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 231
TABLE 332 LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 232
TABLE 333 LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 232
TABLE 334 LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 232
12.5.2 BRAZIL 233
12.5.2.1 Advancements in research capabilities to favor market growth 233
TABLE 335 BRAZIL: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 233
TABLE 336 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 337 BRAZIL: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 338 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 339 BRAZIL: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 235
TABLE 340 BRAZIL: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 235
TABLE 341 BRAZIL: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 235
TABLE 342 BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 236
TABLE 343 BRAZIL: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 236
12.5.3 REST OF LATIN AMERICA 236
TABLE 344 REST OF LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 237
TABLE 345 REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 346 REST OF LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 347 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 348 REST OF LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 238
TABLE 349 REST OF LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 239
TABLE 350 REST OF LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 239
TABLE 351 REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 239
TABLE 352 REST OF LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 240
12.6 MIDDLE EAST & AFRICA 240
12.6.1 INCREASING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET 240
12.6.2 RECESSION IMPACT 240
TABLE 353 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 241
TABLE 354 MIDDLE EAST & AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 355 MIDDLE EAST & AFRICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 356 MIDDLE EAST & AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 357 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 242
TABLE 358 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 242
TABLE 359 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 243
TABLE 360 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 243
TABLE 361 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 243
13 COMPETITIVE LANDSCAPE 244
13.1 OVERVIEW 244
13.2 STRATEGIES ADOPTED BY KEY PLAYERS 244
FIGURE 32 KEY PLAYER STRATEGIES IN BIOBANKING MARKET, JANUARY 2020–APRIL 2023 245
13.3 MARKET SHARE ANALYSIS 246
FIGURE 33 BIOBANKING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 246
TABLE 362 BIOBANKING MARKET: DEGREE OF COMPETITION 246
13.4 REVENUE SHARE ANALYSIS 248
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 248
13.5 COMPANY EVALUATION QUADRANT 248
13.5.1 STARS 249
13.5.2 EMERGING LEADERS 249
13.5.3 PERVASIVE PLAYERS 249
13.5.4 PARTICIPANTS 249
FIGURE 35 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT, 2022 250
13.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 250
13.6.1 PROGRESSIVE COMPANIES 250
13.6.2 STARTING BLOCKS 250
13.6.3 RESPONSIVE COMPANIES 251
13.6.4 DYNAMIC COMPANIES 251
FIGURE 36 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2022 251
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS 252
TABLE 363 BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 252
TABLE 364 BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 252
13.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 253
13.7.1 COMPANY FOOTPRINT ANALYSIS 253
TABLE 365 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS 253
13.7.2 END USER FOOTPRINT ANALYSIS 254
TABLE 366 END USER FOOTPRINT ANALYSIS OF KEY PLAYERS 254
13.7.3 REGIONAL FOOTPRINT ANALYSIS 255
TABLE 367 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 255
13.8 COMPETITIVE SCENARIO AND TRENDS 256
TABLE 368 BIOBANKING MARKET: DEALS, JANUARY 2020–APRIL 2023 256
TABLE 369 BIOBANKING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020–APRIL 2023 257
TABLE 370 BIOBANKING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023 257
14 COMPANY PROFILES 258
14.1 KEY PLAYERS 258
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
14.1.1 THERMO FISHER SCIENTIFIC INC. 258
TABLE 371 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 258
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 259
14.1.2 PHC HOLDINGS CORPORATION 267
TABLE 372 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW 267
FIGURE 38 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021) 268
14.1.3 BECTON, DICKINSON AND COMPANY 272
TABLE 373 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 272
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 273
14.1.4 QIAGEN N.V. 277
TABLE 374 QIAGEN N.V.: COMPANY OVERVIEW 277
FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 278
14.1.5 MERCK KGAA 281
TABLE 375 MERCK KGAA: COMPANY OVERVIEW 281
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) 282
14.1.6 AVANTOR, INC 284
TABLE 376 AVANTOR, INC.: COMPANY OVERVIEW 284
FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2022) 285
14.1.7 CRYOPORT, INC. 290
TABLE 377 CRYOPORT, INC.: COMPANY OVERVIEW 290
FIGURE 43 CRYOPORT, INC.: COMPANY SNAPSHOT (2022) 291
14.1.8 TECAN TRADING AG 294
TABLE 378 TECAN TRADING AG: COMPANY OVERVIEW 294
FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022) 295
14.1.9 AZENTA, INC. 298
TABLE 379 AZENTA, INC.: COMPANY OVERVIEW 298
FIGURE 45 AZENTA, INC.: COMPANY SNAPSHOT (2022) 299
14.1.10 GREINER AG 302
TABLE 380 GREINER AG: COMPANY OVERVIEW 302
FIGURE 46 GREINER AG: COMPANY SNAPSHOT (2021) 303
14.2 OTHER PLAYERS 305
14.2.1 HAMILTON COMPANY 305
14.2.2 MICRONIC 306
14.2.3 AMSBIO 307
14.2.4 BAY BIOSCIENCES LLC 308
14.2.5 BIOKRYO 309
14.2.6 SPT LABTECH 310
14.2.7 ASKION GMBH 311
14.2.8 CELL&CO BIOSERVICES 312
14.2.9 ZIATH LTD. 312
14.2.10 CTIBIOTECH 313
14.2.11 CURELINE 314
14.2.12 FIRALIS GROUP 315
14.2.13 SOPACHEM 315
14.2.14 PROTEOGENEX 316
14.2.15 US BIOLAB CORPORATION, INC. 316
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX 317
15.1 DISCUSSION GUIDE 317
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 321
15.3 CUSTOMIZATION OPTIONS 323
15.4 RELATED REPORTS 323
15.5 AUTHOR DETAILS 324